360 likes | 1.18k Views
CTD Content Management. Michelle Herrera Foster, Ph.D. Regulatory Affairs Consultant. Objectives. To present the use of the CTD/eCTD as a tool for content and document management throughout development to meet the goal of marketing approval and maintenance
E N D
CTD Content Management Michelle Herrera Foster, Ph.D. Regulatory Affairs Consultant
Objectives • To present the use of the CTD/eCTD as a tool for content and document management throughout development to meet the goal of marketing approval and maintenance • To discuss meeting the needs of the development program with effective use of submission-ready documents, document management, and workflow processes. • Examples from Module 3 will be presented.
Module 2 NonclinicalOverview ClinicalOverview NonclinicalSummary ClinicalSummary NonclinicalStudy Reports ClinicalStudy Reports Quality Module 3 Module 4 Module 5 ICH M4 NOT Part of the CTD RegionalAdminInformation Module 1 The CTD QualityOverallSummary
The Common Technical Document (CTD) • Required in EU, Japan, and Canada for marketing applications • “Highly recommended” by FDA for NDA, BLA: • FDA follows ICH guidance • Good Guidance Practices (9/00) require that CTD not be mandatory • Required by CDER for eCTD submissions • Required in EU (IMPD) and Canada for investigational applications; accepted by FDA for IND
DRM Needs in CTD Preparation • Manage filing of information for ready accessibility by contributors, authors, and reviewers from IND to NDA • Develop shared databases in submission-ready templates, e.g. stability data • Agree on standards for terminology, product names, cross-references, etc. • Meet Quality standards and traceability to source documents; Quality Systems • Define content early to prepare and expand/update submission-ready documents throughout development (IND to NDA)
Module 2 NonclinicalOverview ClinicalOverview NonclinicalSummary ClinicalSummary NonclinicalStudy Reports ClinicalStudy Reports Quality Module 3 Module 4 Module 5 From IND to NDA NOT Part of the CTD RegionalAdminInformation Module 1 Phase 1: Focus on Safety NDA: Complete Details The CTD QualityOverallSummary
Module 2 NonclinicalOverview ClinicalOverview NonclinicalSummary ClinicalSummary NonclinicalStudy Reports ClinicalStudy Reports Quality Module 3 Module 4 Module 5 From IND to NDA NOT Part of the CTD RegionalAdminInformation Module 1 Introduce Protocols and Study Reports at each phase The CTD QualityOverallSummary
Building the NDA from Phase 1 P.1 P.2 P.3 P.4 P.5 P.6 P.7 P.8 S.1 S.2 S.3 S.4 S.5 S.6 S.7 Development Plan Pre-IND IND NDA, DMF Post-Approval
Marketing Goals: the NDA • Label Claims, Target Product Profile • Clinical Studies that support the label • Nonclinical Studies that support the clinical plan • CMC Data for the commercial product • Meet regulatory guidelines, standards, and agreements for approval • Set your strategy with CTD summaries (Module 2)
Why CTD content management? • Global harmonization of submission content (regional differences are handled in a modular fashion) • Standardization of submission format from clinical to marketing; from IND to NDA • Allows for preparation of submission-ready document templates • Facilitates life cycle management
Submission-Ready Documents • Build the marketing application from Ph 1 to NDA and post-marketing • The modular approach to writing submissions; capture regional differences • Each section/attachment is a technical report, or a section within the report • Meet eCTD granularity rules; eCTD-ready • More efficient use of resources, expedites submissions, less cost and stress to the organization
Levels of Submission-Ready Reports (Module 3) Key results, conclusions For QOS Summary Summary of methods Module 3 data Body of Report Key Tables, Figures, Graphs Discussion Complete data GMP Info Appendices May not be submitted, on file Protocols
CTD/eCTD Templates • Define content and format for each section/report, granularity for eCTD • IND NDA content for use throughout the development process; gap analysis • Address CTD, ICH, agency guidance • Address agency agreements • Customized for each product • May be expanded into model reports
Why CTD Document Management? • The world revolves around regulatory (!) • Product approval and regulatory compliance are highest priorities • Now there is global standardization; no excuse not to “file” according to the CTD • Shared databases enhance communication, transparency, efficiency, and co-operation • Quality Systems requirements (ICH Q10)
Shared Info and Databases Example: Control of Drug Product: • 3.2.P.5.1 Specifications • 3.2.P.5.2 Analytical Procedures • 3.2.P.5.3 Method Validation • 3.2.P.5.4 Batch Analysis • 3.2.P.5.5 Characterization • 3.2.P.5.6 Justification of Specifications
CTD Mapping • Map source documents and related data to each section of the CTD • For example: 3.2.P.5.4 Batch Analysis: • Certificates of Analysis • Raw data: chromatograms, etc. • Statistical analyses • Trend analyses • Batches in each phase of development • Information on batches • Get management approval of the MAP
Batch # Mfg Date Mfg Site Batch Size Process Intended Use Clinical Clinical studies Commer-cial Stability studies Description of Batches
The CTD Team • Set submission strategy • Define submission content • Author standardized documents • Make documents accessible • Work with the extended team: • Regional offices • Business partners • Contract manufacturers, other contractors
CTD Workflow CTD, eCTD Workflow Document Management Submission-Ready Documents Content Management
Start Early in Development • CTD Content Management: • Templates from IND to NDA • Submission-Ready documents • CTD Document Management • CTD Mapping • CTD Repository, filing strategies • Get Management Approval up front • Get CTD Team ready from the start • Put this in everyone’s Objectives
Conclusions • Merge document management and submission management to align marketing goals early in development • This promotes clear communication, transparency, and teamwork • Submission-ready documents written with CTD/eCTD templates from IND to NDA enhance efficiency • CTD document management facilitates traceability in quality systems
Contact Information Michelle Herrera Foster, Ph.D. CTD Quality Consulting Michelle@ctdquality.com 978-356-0872 www.ctdquality.com NOTE: Survey of CTD/eCTD needs and solutions for module 3 in progress.